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Abstract In this study, we deﬁne the correlation
between LV volumes (both LV end-diastolic volume
[LVEDV] and LV end-systolic volume [LVESV])
and ejection fraction (EF) on 64 slice multi-detector
computed tomography (MDCT). We also determine
the accuracy of all the LV volume (LVV) parameters
to detect LV systolic dysfunction (LVSD) and
investigate the feasibility of using LVV as a surrogate
of LVSD on prospectively gated imaging to prevent
the radiation exposure of retrospective imaging. 568
patients undergoing 64-detector MDCT were divided
into 2 groups: Group 1—subjects without any heart
disease and LVEF C 50%; and Group 2—patients
with coronary artery disease and LVEF \50%
(deﬁned as LVSD). The LVV (LV cavity only) and
Total LV volume (cavity ? LV mass) at end-systole
and end-diastole (LVESV, Total LVESV, LVEDV
and Total LVEDV) were measured. The upper limit
values (mean ? 2 SD) of all LVV parameters in
Group 1 were used as the reference criterion to
diagnose LVSD in Group 2. An exponential correla-
tion was found between LVEF and all the LVV
parameters. The speciﬁcity to detect LVSD in Group
2 was[90% and the sensitivity was 88.9, 83.3, 61.3
and 74.9% by using LVESV, Total LVESV, LVEDV
and Total LVEDV, respectively. Systolic and
diastolic LV volumes had a high correlation with
LVEF and a high accuracy to detect LVSD. Thus, on
prospectively triggered imaging, ventricular volumes
can predict patients with reduced LVEF, and appro-
priate referrals can be made.
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Introduction
Left ventricular (LV) systolic function and LV
volumes are the fundamental parameters for diagno-
sis, disease stratiﬁcation, prognosis estimation, and
therapeutic management of ischemic and non-
ischemic cardiomyopathy. LV volume (LVV) and
myocardial mass are independent predictors of mor-
bidity and mortality among patients with coronary
artery disease (CAD), and global LV function is
considered the strongest determinant of heart failure
and death due to myocardial infarction. Due to its
prognostic relevance, accurate and reproducible
determination of LV volumetric and functional
parameters is a major clinical requirement for diag-
nosis and risk stratiﬁcation of patients with suspected
or documented heart disease [1–4].
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sured with Multi-detector computed tomography
(MDCT) have been found to be in good agreement
with echocardiography, cine ventriculography, sin-
gle photon emission computed tomography (SPECT)
and cardiac magnetic resonance imaging (CMRI)
[5–9]. ECG-gated MDCT of the heart can provide
retrospective quantitative information on LV volume
changes through all the phases of cardiac cycle
(R–R interval) and consecutive information on
global LV function [9]. However, with the recently
increased concern for radiation exposure, new
MDCT protocols scanner use prospectively acquired
ECG gated image acquisition to obtain images at
certain phases of cardiac cycle with least coronary
motion. These protocols do not allow assessment of
functional data which involves measurement of
ejection fraction [EF] requiring end-systolic and
end-diastolic phases.
LV end-diastolic volume (LVEDV) and LV end-
systolic volume (LVESV) have been validated to
diagnose and follow LV volumetric and functional
abnormalities on echocardiography, CMRI and LV
angiogram [10–15]. In this study, we aim to deﬁne
the correlation between LV volumes (LVEDV and
LVESV) and ejection fraction on 64 slice MDCT.
We also determine the accuracy of all the LVV
parameters to detect LV systolic dysfunction
(LVSD) and investigate the feasibility of using
LVV as a surrogate of LVSD on prospectively gated
image acquisition. This would result in assessment
of LV function along with interpretation of coronary
arteries with prospective imaging, without exposing
the patient to the radiation dose of retrospective
imaging.
Methods
Study population
This study consisted of 568 consecutive patients who
underwent 64 slice MDCT at our center (Los Angeles
Biomedical Research Institute at Harbor-UCLA)
from September 2006 to June 2009. The various
indications for the study included: chest pain, short-
ness of breath, abnormal or equivocal stress test,
cardiomyopathy, congestive heart failure, or syncope.
Patients were excluded if found to have an irregular
heart rate, allergy to contrast medium or impaired
renal function. The study was approved by the local
Institutional Review Board of our hospital.
The patients were divided into two groups: Group
1 included subjects without any coronary artery
disease, hypertension, lung disease or any wall
motion abnormalities having a normal LVEF C 50%
(n = 281); Group 2 included patients with coronary
artery disease and a LVEF of \50% (n = 287)
(Table 1).
Patient preparation
The patients were prepared in usual manner as
described in earlier studies. In brief, patients received
explanation about the procedure and informed consent
was obtained. Upon arrival to our center, if the
patient’s base line heart rate [HR] was more than
80 bpm, 100 mg of atenolol was given orally and the
patient was asked to wait for 1 h. Alternatively, if
the HR \80 bpm the patient was placed on the
scanner without any delay. On the scanner, if the HR
was [60 bpm, intravenous (IV) metoprolol was
Table 1 Demographics and Classiﬁcations of Studied Individuals
Gender N Age (year) Weight (kg) Height (cm) BSA (m
2) Heart rate (BPM) LVEF (%)
Group 1 (n = 281)
Female 115 57.1 71.0 161.5 1.74 57.8 65.3
Male 166 54.3 89.4 177.0 2.06 55.8 63.8
Group 2 (n = 287)
Female 75 63.1 161.9 62.9 1.75 58.7 36.1
Male 212 61.4 190.8 69.7 2.03 57.6 34.4
Group 1 = patients without any heart disease and a normal LV Ejection Fraction (LVEF) C 50%
Group 2 = patients with coronary artery disease and a LVEF of\50%
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123administered in doses of 5 mg every 1 min until the
HR was brought below 60 bpm or a total IV dose of
40 mg was given or the systolic blood pressure (SBP)
dropped to \90 mm Hg. Intravenous diltiazem was
also used to complement the beta blocker if needed.
ThreephaseinjectionusingaDualBarrelInjectorwith
contrast/saline mix was administered intravenously as
follows: 5 ml/s for 12 s (60 ml contrast), then 5 ml/s
for 10 s (50–20 ml contrast plus 30 ml saline) and
ﬁnally 5 ml/s for 4 s (20 ml of saline), injection
protocols were varied based upon patient characteris-
tics (length of heart, heart rate, body habitus).
MDCT study protocol
All the Coronary Computed Tomography Angiogra-
phy (CCTA) studies were completed with 64 MDCT
(LightSpeed VCT, General Electric Medical Systems,
Milwaukee, WI). The technique of the cardiac
retrospective overlapping helical acquisition was
completed using a 0.35-s scan gantry rotation speed
and a 64 9 0.625 mm collimation. The reconstruc-
tion ﬁeld of view was small (12–17 cm, mean 15 cm)
with a voxel size of 0.35 9 0.35 9 0.6 mm
3.A n
energy setting of 120 kVp was used for patients
weighing C85 kg. For patients who were\85 kg, an
energy setting of 100 kVp was selected. The tube
current time product (mAs) was 200–770, determined
individually based on the body habitus and weight.
The total scan time was about 5–6 s. The target HR
was 50–60 beats/min, achieved using oral and intra-
venous beta blockers as described above. After scan
completion, multi-phase reconstruction of the CCTA
scans was performed, with reconstructed images from
5 to 95% phases by 10% increments [16]. All CCTA
images were transferred to a reading center for
3-dimensional image analysis on Advantage
Windows (AW) 4.4 Workstation (General Electric
Medical Systems, Milwaukee, WI).
LVV and LV ejection fraction measurement
with 64 slice MDCT
All LV segmentations were measured by using 64
slice MDCT retrospective multi-phase images. A
global estimation of wall motion was initially done.
Then the axial images with minimum and maximum
diameter were chosen for manual segmentation
analysis to calculate the LV end-systolic and end-
diastolic diameters, respectively. The segmentation
analysis included delineation of LV endocardial
boundary at end-systole (to calculate LVESV includ-
ing only the LV cavity) and epicardial boundary at
both end-diastole and end-systole (to calculate Total
LVEDV and Total LVESV including the LV cavity
and the LV mass). The endocardial tracing was only
done in end-systole to decrease the CT partial volume
effect since the trabeculae and papillary muscle could
be separated from the cavity signiﬁcantly in these
images. The LVEDV was computed by the following
formula (Fig. 1)[ 17, 18]:
Stroke volume (SV) ¼ Total LVEDV
  Total LVESV; and LVEDV ¼ SV þ LVESV
In each study, 10–14 axial slice levels were traced,
while the remaining slices were automatically traced
by the workstation, and visually conﬁrmed by the
reader. The volume measured by the endocardial and
epicardial tracing lines corresponded to LV cavity
volume (LVV) and Total LV volume (inclusive of
LVV ? LV mass), respectively. Volumes were
calculated in two workstations using modiﬁed Simp-
son’s method, in which the sum of cross-sectional
areas was multiplied by the sum of slice thicknesses.
The LVEF was then computed by the formula
[17, 18]: LVEF = SV/LVEDV 9 100% (Fig. 1).
Statistical analysis
The data was analyzed using SPSS 15 statistical
software. Categorical variables were analyzed using
Chi-square test and Continuous variables using
student t test. Mean values and Standard Deviations
(SD) of all the LVV measurements were calculated.
The correlation between LV volumes and gender and
body surface area (BSA) was calculated by using the
Pearson’s method. Considering the signiﬁcant linear
association between LV volumes, and gender and
body size (r[0.3, P\0.05 for all), the gender and
BSA speciﬁc LV volumes were calculated for all
measurements. All subsequent analyses were per-
formed using LV volume indexes. T test was used to
test the difference between genders and the two
groups. For all analyses, a criterion for statistical
signiﬁcance was set at a 2-tailed P value\0.05.
The correlation of LVEF with all the LVV
parameters was determined and correlation coefﬁcient
Int J Cardiovasc Imaging (2011) 27:1015–1023 1017
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2) calculated. The upper limit values (2 SD above the
mean) of all LVV parameters in Group 1 were then
used as the reference criteria to diagnose LVSD in
Group 2. LVSD was deﬁned as LV ejection fraction
\50%, measured by MDCT. The accuracy of these
reference criteria (95th percentile) to diagnose LVSD
in Group 2 was then computed.
Results
Themeanageforthispatientcohortwas61.7 yearsand
38%werefemales.ThemeanvaluesforLVESV,Total
LVESV, LVEDV and Total LVEDV as computed in
Group 1 were 19.3 ± 6.9, 88.1 ± 14.9, 54.3 ± 13.2,
and 123.2 ± 20.19 ml/m
2 and the upper limit values
calculated as above (2 SD above the mean) were 33,
118, 81 and 163 ml/m
2, respectively (Table 2).
Using the upper limits as the reference values, the
speciﬁcity to detect LV systolic dysfunction in Group
2 was[90% and the sensitivity was 88.9, 83.3, 61.3
and 74.9% by LVESV, Total LVESV, LVEDV and
Total LVEDV parameters, respectively. Area under
the curve (AUC) was also computed to determine the
accuracy of all the LVV parameters to detect LVSD.
(Fig. 2; Table 3).
An exponential correlation was found to exist
between the LVEF and the LVESV (r
2 = 0.74), Total
LVESV (r
2 = 0.64), LVEDV (r
2 = 0.48) and Total
LVEDV (r
2 = 0.49). Thus, all the LVV parameters
had a good correlation with LVEF and a high
sensitivity and speciﬁcity to detect LV systolic
dysfunction. (Fig. 3; Table 3).
Discussion
Traditional acquisition protocol for CCTA has been
to obtain all phases of the cardiac cycle (R–R
interval) allowing calculation of EF simultaneously
with plaque burden. Recently increased concern for
radiation exposure has led to a shift towards
prospectively triggered acquisition protocols for
CCTA imaging [19]. These protocols target speciﬁc
Fig. 1 LVV and LVEF measurement by 64 MDCT. Right and
left panels represent systolic and diastolic phases, respectively.
The LV cavity volume at end-systole (LVESV) was traced
manually, marked as the inner purple line. The total LV
volume at end-diastole and systole (Total LVEDV and Total
LVESV including the LV mass and cavity) were traced and
marked as the outer green line. LVV was traced and Total
LVVwas calculated automatically bymultiplication of summed
areatothethicknessofslice.TheLVEFwascomputedmanually
through: LV stroke volume (SV) = Total LVEDV - Total
LVESV, LVEF = SV/(LVESV ? SV) 9 100%. LA left
atrium; LV left ventricle; RA right atrium; RV right ventricle
Table 2 Proﬁle of mean
values and upper limits for
all the LV volume
parameters
Model Mean ± SD Group 1
(ml/m
2)
Upper limit of normal
(ml/m
2) (mean ? 2 SD)
Mean ± SD Group 2
(ml/m
2)
LVESV 19.3 ± 6.9 33 64.2 ± 42.6
Total LVESV 88.1 ± 14.9 118 162.7 ± 60.0
LVEDV 54.3 ± 13.2 81 92.4 ± 46.6
Total LVEDV 123.2 ± 20.2 163 192.6 ± 65.2
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123phases of the R–R interval that have been shown to
produce the best coronary image quality but do not
allow assessment of functional data which involves
measurement of ejection fraction requiring end-
systolic and end-diastolic phases. Gerber et al. pro-
vided a comprehensive scientiﬁc statement on radi-
ation doses from the American Heart Association and
estimated the doses for retrospective CCTA at 15
milli Seivert (mSv) without tube modulation, 9 mSv
with dose modulation and 3 mSv for prospectively
acquired studies [20]. Minimizing radiation exposure
through ECG triggered X-ray tube activation is a step
towards making CCTA safer.
In our study we reviewed the CCTA’s performed
by retrospectively triggered 64 slice MDCT of 568
patients to determine the correlation between LV
volumes and ejection fraction on MDCT. Our goal
was to investigate the feasibility of using LVV as a
surrogate of LVSD on prospectively gated image
acquisition. We found that all the LVV parameters
had a signiﬁcant correlation with LVEF and were
found to be sensitive indicators of LVSD. As more
cardiac CT studies are obtained in prospective (single
phase) mode to reduce radiation exposures, clinicians
can use increased ventricular volume as a marker of
reduced LVEF and consider further evaluation,
increasing the yield of prospective studies without
incremental radiation exposure.
An interesting observation in our study was that
amongst all the LVV parameters, LVESV was the
most sensitive (88.9%), speciﬁc (92.9%) and accurate
(AUC-0.96) in detecting LVSD. LVESV has been
shown to have important implications in literature.
Increase in LVESV after exercise independently
predicts mortality in patients with CAD and provides
useful complementary information for risk stratiﬁca-
tion [21]. It is also an indicator of remodeling after
myocardial necrosis from infarction [22, 23], having
a greater predictive value than EF or LVED with the
latter two not adding any prognostic value [3, 24].
The association of resting LVESV to mortality and
incident heart failure is also known [25]. During
stress or exercise, EF may not adequately reﬂect
contractile reserve since the EF is affected by loading
conditions and is largely driven by the degree of LV
dilatation. In comparison, LV volume may be a more
sensitive indicator of ventricular function, especially
at the limits of contractile reserve where contractility
is unable to match the physiologic increase in preload
and after load during exercise [21]. LV volumes are
easily measurable and reproducible, less sensitive to
cardiac loading and vary greatly in response to
changes in contractility.
LV dilation results from infarct expansion [26] due
to slippage of the necrotic ﬁbers on one another as the
infarct stretches during systole [27]. Infarct expan-
sion occurs between 3 days and 2 weeks after
Fig. 2 Receiver-operating characteristic (ROC) curve for
accuracy of LV volume parameters to detect LV systolic
dysfunction
Table 3 Accuracy of LV volume parameters to diagnose LV systolic dysfunction
Model AUC (±SE) Sensitivity (%) Speciﬁcity (%) P value 95% CI r
2 with EF
LVESV 0.96 (0.008) 88.9 92.9 0.0001 0.94–0.98 0.74
Total LVESV 0.94 (0.01) 83.3 95.4 0.0001 0.92–0.96 0.64
LVEDV 0.84 (0.01) 61.3 96.8 0.0001 0.81–0.87 0.48
Total LVEDV 0.88 (0.01) 74.9 91.1 0.0001 0.85–0.91 0.49
AUC area under the receiver-operating curve, SE standard error
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123infarction [28], and patients showing expansion by
10–21 days after transmural infarction may continue
to have expansion over a period of 6–30 months [29].
Infarct expansion would increase LV systolic and
diastolic volumes with resultant increase in wall
stress, which in turn may act as a stimulus to cardiac
hypertrophy [30]. Thus, LV dilation after infarction
has been identiﬁed as a major risk factor for
subsequent cardiac death [3].
To date, ventricular dimensions have most com-
monly been assessed by echocardiography or in
patients undergoing invasive catheterization, by left
ventriculography based on mono or biplane projec-
tions. However, both measurements rely on geomet-
ric assumptions about ventricular structure [9].
MDCT can accurately differentiate the endocardial
and epicardial boundaries with high spatial resolution
and provide detailed information of cardiac structures
that allows precise measurement of the chamber
volume without assumptions regarding geometry
[17]. In the evaluation of cardiac function and
chamber volumes, MDCT with a temporal resolution
of 125–250 ms and high spatial resolution has been
shown to be a promising alternative to echocardiog-
raphy, biplanar cine ventriculography, SPECT and
CMRI [9].
In the present study, we demonstrated all the LVV
parameters had a high correlation with LVEF and a
high sensitivity to detect LVSD. Thus, MDCT-
measured LVV could be used as a complementary
or conﬁrmatory parameter to LVEF in early diagnosis
of LVSD. LV volumes may also serve as a surrogate
for LVEF whenever its estimation is technically
difﬁcult or impossible due to various reasons. This
may increase the conﬁdence of clinicians in diagnosis
and early management of LVSD and prevent further
progression of disease. As prospectively triggered
scans are unable to measure LVSD [31], using
Fig. 3 a Correlation between LV ejection fraction and LV
end-systolic volume. b Correlation between LV ejection
fraction and Total LV end-systolic volume. c Correlation
between LV ejection fraction and LV end-diastolic volume.
d Correlation between LV ejection fraction and Total LV end-
diastolic volume
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123ventricular volumes as a marker of LVSD on these
scans can lead to a signiﬁcant radiation dose reduc-
tion in comparison to getting a retrospective ECG-
gated CT scan for the same information.
In a prospective triggered scan, depending on
patient’s heart rate and its regularity, the single
acquired phase is usually neither the LVEDV nor the
LVESV. Additionally, in our study, LVESV showed
to be the most accurate parameter in detecting LVSD,
but LVESV is normally not determined in prospec-
tive triggered CCTA. LVEDV, which matches most
closely to the mid-diastole LV volume measured in
prospective triggered CCTA [31], however, showed
only a fair sensitivity to detect LVSD (61%). Hence
based on our study, the transfer of the results of
retrospective gated scans to prospectively triggered
CCTA is limited but gives a foundation to future
studies to further validate this concept.
Limitations
Our study has some limitations. Although LV
volumes measured with MDCT have shown good
correlation with the values obtained by CMRI in
various studies, currently CMRI is the non-invasive
diagnostic standard of reference for determination of
LV volumes demonstrating a high diagnostic accu-
racy and low inter and intra-observer variability.
With a lower temporal resolution than CMRI, MDCT
is more susceptible to motion artifacts, especially
during systole and atrial contraction. Because of this,
systolic images obtained in patients with a higher
heart rate, are of lower quality and may impair
delineation of endocardial contours [9]. Also, the
measurements for LVEF in our study were made on
MDCT. Having a reference standard for LVSD in
terms of echocardiography or CMRI would have
further strengthened our ﬁndings.
Secondly, not all the patients can be scanned using
prospective ECG triggered CT image acquisition, a
common example being patients with atrial ﬁbrilla-
tion. The maximum dose saving is achieved using the
shortest acquisition window, which does not allow
any ﬂexibility in post acquisition phase adjustment.
This can potentially result in sub-optimal image
quality and compromise the diagnostic value of the
exam.
The measurement of LV volumes as described in
our study can be tedious and cumbersome to do in
daily clinical practice. However, this has been done
for research purpose for this validation study. In
routine practice, physicians can use the automatic
software programs available on every CCTA reading
workstations to compute LV volumes. For e.g: LV
volumes can be generated using the ‘Auto Ejection
Fraction’ program on Advantage Windows (AW)
workstation.
Conclusion
The results of our study demonstrate that all the LV
volume parameters on CT allow detection of LVSD.
Since MDCT-derived LV volumes are easy to
measure and highly reproducible, they can be used
for early detection of LVSD as a surrogate or in
addition to LVEF to facilitate early management and
prevent further progression of congestive heart fail-
ure. Since most CT studies will be utilizing prospec-
tive triggering and thus unable to measure LVSD,
measure of LV volume should provide important
information to the interpreting physician as to the
presence of possible LV dysfunction, without expos-
ing the patient to the radiation dose of retrospective
imaging.
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